Company profile: HeartBeam
1.1 - Company Overview
Company description
- Provider of a 3D-vector electrocardiogram (VECG) platform for remote cardiac monitoring and 12-lead ECG generation. Offerings include HeartBeam AIMIGo, a portable credit card-sized device that captures and converts heart electrical signals to a 12-lead ECG; core VECG technology delivering diagnostic and prognostic insights; HeartBeam Cloud Service for analysis and on-call physician review; and the AIMIGo App guiding recording and transmission.
Products and services
- VECG Technology: 3D-vector platform that captures three-dimensional projections of cardiac electrical activity and converts them into a 12‑lead ECG, enabling diagnostic and prognostic insights
- HeartBeam AIMIGo™: Portable, credit card-sized device that captures the heart’s electrical signals and converts them into a 12‑lead ECG for remote cardiac monitoring
- HeartBeam Cloud Service: Cloud-based platform that analyzes 3D VECG signals, converts them into a 12‑lead ECG, and routes results for review by an on‑call physician
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to HeartBeam
Defibtech
HQ: United States
Website
- Description: Provider of automated external defibrillators and resuscitation devices, including Lifeline AED for public access and healthcare facilities, Lifeline ECG AED with dual AED mode and real-time ECG waveform display for healthcare providers and professional rescuers, and automated chest compression systems (ARM XR ACC and Lifeline ARM ACC) delivering continuous mechanical CPR for EMS use.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Defibtech company profile →
Corthera
HQ: United States
Website
- Description: Provider of biopharmaceutical acquisition, development and commercialization of therapies for illnesses in the acute care setting; lead product candidate relaxin is being evaluated in a global phase 2/3 clinical trial for acute decompensated heart failure.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Corthera company profile →
Arrow International
HQ: United States
Website
- Description: Provider of disposable catheters and related products, manufacturing and marketing a broad range of offerings.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arrow International company profile →
Access Vascular
HQ: United States
Website
- Description: Provider of medical devices utilizing novel bulk hydrophilic-based technology to improve venous access.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Access Vascular company profile →
Adona Medical
HQ: United States
Website
- Description: Provider of heart failure management systems, including the Adona Interatrial Shunt with integrated bi-atrial pressure monitoring enabling individualized shunting; bi-atrial pressure sensors delivering direct LA and RA readings with >5 automated readings/day; shape memory Nitinol shunt lumen adjustment technology; and the Adona Induction Catheter for non-contact inductive energy transfer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adona Medical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for HeartBeam
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to HeartBeam
2.2 - Growth funds investing in similar companies to HeartBeam
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for HeartBeam
4.2 - Public trading comparable groups for HeartBeam
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →